ARTICLE | Clinical News
Intuniv guanfacine GXR regulatory update
June 25, 2007 7:00 AM UTC
SHP received an approvable letter from FDA for Intuniv guanfacine (formerly Connexyn) extended-release tablets to treat ADHD in children and adolescents aged 6-17. The company said that FDA did not r...